D A Van Echo
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
-
- Neuroendocrine Tumor Research Advances
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 5
- Lung Cancer Research Studies 4
- Peptidase Inhibition and Analysis 2
- Cutaneous Melanoma Detection and Management 1
-
- Acute Myeloid Leukemia Research 3
- Co-authors
- Joseph Aisner (12 shared papers)Wiernik Ph (14 shared papers)Margaret Y. Whitacre (3 shared papers)E S Henderson (1 shared paper)Rosemarie Mick (1 shared paper)Harvey Schipper (1 shared paper)Martin Levitt (1 shared paper)
- Journals
- PubMed (18 papers)
- Partner nations
- United States
In The Last Decade
D A Van Echo
18 papers receiving 358 citations
Peers
Comparison fields: 5 of 48
- Oncology 308
- Epidemiology 161
- Hematology 51
- Pulmonary and Respiratory Medicine 127
- Pathology and Forensic Medicine 50
Countries citing papers authored by D A Van Echo
This map shows the geographic impact of D A Van Echo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D A Van Echo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D A Van Echo more than expected).
Fields of papers citing papers by D A Van Echo
This network shows the impact of papers produced by D A Van Echo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D A Van Echo. The network helps show where D A Van Echo may publish in the future.
Co-authors
The 7 scholars most cited alongside D A Van Echo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations. | 1982 | 114 |
| 2 | Value of prophylactic cranial irradiation given at complete remission in small cell lung carcinoma. | 1983 | 96 |
| 3 | Phase I clinical and pharmacologic trial of carboplatin daily for 5 days. | 1984 | 67 |
| 4 | High-dose VP 16-213 (NSC 141540) for the treatment of patients with previously treated acute leukemia. | 1980 | 21 |
| 5 | Vinblastine, 5-azacytidine, and VP-16-213 therapy for previously treated patients with acute nonlymphocytic leukemia. | 1977 | 19 |
| 6 | CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma. | 1982 | 19 |
| 7 | Phase II trial of mitoxantrone in advanced primary liver cancer: a Cancer and Leukemia Group B Study. | 1986 | 18 |
| 8 | Phase II evaluation of N-(phosphonacetyl)-L-aspartic acid (PALA) in metastatic adenocarcinoma of the colon or rectum. | 1980 | 12 |
| 9 | Phase I trial of pentamethylmelamine in patients with previously treated malignancies. | 1980 | 9 |
| 10 | Phase I trial of dihydroxyanthracenedione. | 1981 | 9 |
| 11 | Phase I trial of aclacinomycin A. | 1982 | 8 |
| 12 | Phase I study of neocarzinostatin in patients with acute leukemia. | 1978 | 8 |
| 13 | Phase II evaluation of AMSA in patients with stage III--IV malignant melanoma. | 1982 | 6 |
| 14 | Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinoma. | 1981 | 5 |
| 15 | Phase II trial of methyl-G (methylglyoxal bis-guanylhydrazone) in patients with metastatic renal cell carcinoma. | 1981 | 4 |
| 16 | Phase I-II trial of anthracenedicarboxaldehyde in patients with refractory adult acute leukemia. | 1984 | 4 |
| 17 | Phase II study of deoxydoxorubicin in patients with advanced liver cancer. | 1987 | 3 |
| 18 | Treatment of advanced non-small cell lung cancer with bisantrene. | 1983 | 3 |
About D A Van Echo
D A Van Echo is a scholar working on Oncology, Hematology, Genetics, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 425 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Lung Cancer Research Studies (4 papers), Acute Myeloid Leukemia Research (3 papers), Neuroendocrine Tumor Research Advances (3 papers), Peptidase Inhibition and Analysis (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Glutathione Transferases and Polymorphisms (2 papers) and Cutaneous Melanoma Detection and Management (1 paper). The work is most often cited by research in Oncology (308 citations), Epidemiology (161 citations), Hematology (51 citations), Pulmonary and Respiratory Medicine (127 citations) and Pathology and Forensic Medicine (50 citations). D A Van Echo has collaborated with scholars based in United States. Frequent co-authors include Joseph Aisner, Wiernik Ph, Margaret Y. Whitacre, E S Henderson, Rosemarie Mick, Harvey Schipper and Martin Levitt. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.